Novacyt Announces Financial Results on April 30, 2025

International molecular diagnostics company Novacyt SA plans to release its audited financial results for the year 2024 on April 30, 2025. Listed on both Euronext and AIM, Novacyt will highlight its performance during a webinar on the same day at noon, Paris time.

This webinar, hosted by Lyn Rees, Managing Director, and Steve Gibson, Chief Financial Officer, will be open to all investors. It will include a presentation and a Q&A session, accessible via the Investor Meet Company platform. Participants will be able to submit questions until the day before the event.

Please note that investors already registered on the platform will automatically receive an invitation at no additional cost. This initiative aims to strengthen open and transparent financial communication with shareholders.